Stroke, an infarct in the brain, is the 5th-leading cause of death in the United States. The vast majority of strokes are ischemic in origin and result from occlusion of a cerebral artery by an embolus or thrombus. Hemorrhagic strokes are either intracerebral or subarachnoid and occur when blood from a ruptured vessel damages brain tissue. Venous strokes, due to thrombosis of the venous dural sinuses, are less common but may be associated with hypercoagulability, dehydration, and the use of estrogen.
A transient ischemic attack (TIA) produces similar signs and symptoms and was previously considered fleeting in nature, with absence of clinical sequelae. Advancements in highly sensitive imaging, however, are proving otherwise. What were once considered benign events, therefore, may now be better defined as minor strokes. Experts have recently uncovered that any symptomatic presentation secondary to cerebral ischemia is producing some degree of cerebral tissue injury. Further, many TIAs can be listed as “sentinel” events which can often herald the onset of a larger stroke.
Symptoms of stroke include the following sudden changes:
- Numbness (paresthesia) or weakness (paresis) of the face, arm, or leg, usually on one side of the body
- Confusion, difficulty speaking (dysarthria or aphasia) or understanding
- Visual disturbances, which may include partial or complete vision loss
- Dizziness and/or ataxia
- Severe headache with no known cause—particularly with hemorrhagic strokes
BEFAST is an acronym that helps to spot a stroke and get “fast” treatment, helping to save lives:
- B – Balance: Assess for changes in balance.
- E – Eyes: Look for a change in vision.
- F – Face: Is the face drooping on one side?
- A – Arms: Can the person raise their arms and determine if one arm drifts downward? Or is there any numbness or lack of coordination?
- S – Speech: Does the patient have a sudden change in the ability to speak, or is there difficulty swallowing?
- T – Time: Timely treatment is necessary. Call an emergency line and get to the emergency department by ambulance to ensure timely treatment.
In the United States, Black and Native American individuals have a higher prevalence of stroke, and Black, Asian, Native American, and Latino individuals have higher stroke mortality when compared to white individuals. It is unclear whether these differences are due to environmental (e.g., differential access to medical care) or genetic causes. Other risk factors include:
Age. The risk of stroke doubles every 10 years beyond age 55.,
Gender. Women have a slightly higher incidence of stroke compared with men, and case-fatality rates due to stroke are also higher in women.
Hypertension. As the most important modifiable risk factor, especially for hemorrhagic stroke, both systolic hypertension and diastolic hypertension are associated with an increased risk. (For more information, see Hypertension chapter.)
Smoking. Cigarette smoking increases risk for ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage.
Overweight. Excess body weight is associated with increased ischemic stroke risk.
Diabetes. According to the American Diabetes Association, people with diabetes have a 1.5-times-greater risk of having a stroke. High blood glucose levels are associated with worse outcomes and higher rates of mortality, especially after an ischemic stroke.
Sedentary lifestyle. Higher levels of occupational or leisure-time physical activity protect against stroke. A study of women undergoing coronary angiography found that those with higher activity levels were at significantly lower risk for cardiovascular events, including stroke.
Poor nutrition. High-fat, high-sodium diets and a lack of key nutrients such as folic acid have been associated with increased risk for stroke (see Nutritional Considerations below).
Carotid stenosis. Both symptomatic and asymptomatic stenoses of the internal carotid arteries are associated with increased risk for ischemic stroke.
Atrial fibrillation. In the Framingham Study, patients with atrial fibrillation had 5-fold greater risk of stroke than did their healthy counterparts. Further, the attributable risk of stroke due to atrial fibrillation increased with age from 1.5% for persons aged 50-59 years, to 23.5% for those aged 80-89 years.
Sickle cell anemia. This can manifest as a “silent” cerebral infarction.
Migraine. Studies have found that migraines with aura were strongly associated with risk of stroke and TIA. Hemiplegic and basilar migraines are also risk factors.
Drug abuse. Use of cocaine and amphetamines may result in ischemic or hemorrhagic strokes.
Hormone replacement therapy. Combined and unopposed estrogen therapies raise the risk for stroke. Low-dose oral contraceptives slightly increase the low risk in otherwise healthy young women.
Heart disease, vasculitis, elevated homocysteine levels, anticoagulant use, and bleeding disorders also raise the risk of stroke. Stroke risk is elevated during pregnancy and the postpartum period.
Evaluation should include a detailed history of symptom onset, a thorough physical (including neurologic) examination, and imaging tests to determine whether the stroke is hemorrhagic or ischemic. It is helpful to use a validated scoring system such as the National Institutes of Health Stroke Scale. Evaluation of the cardiac rhythm is also essential. Paroxysmal atrial fibrillation may easily be missed if the patient is not closely monitored. Patients should be admitted to dedicated acute-care stroke units if available in the admitting facility. These units typically provide closer monitoring with neurologic and cardiac telemetry monitoring.
Laboratory tests normally include a complete blood count, blood glucose, erythrocyte sedimentation rate (elevated in temporal arteritis or other vasculitides), lipoprotein and triglyceride levels, and coagulation tests. Young patients and those without cardiovascular risk factors need to be screened for abnormal antiphospholipid antibodies (specifically, lupus anticoagulant).
A non-contrast computed tomography (CT) scan of the brain helps determine whether a stroke is hemorrhagic or ischemic and is the initial study of choice. Areas of infarct due to ischemia, however, are often not acutely visible. Lumbar puncture may help diagnose small subarachnoid hemorrhages, if the CT scan or magnetic resonance imaging (MRI) is negative. CT is necessary before considering thrombolysis, which must be performed within 3 to 4.5 hours of the earliest symptom onset. Newer intravascular techniques may extend this window, but currently they are available only in tertiary care settings.
When a subarachnoid hemorrhage is visualized on CT scan, an aneurysm needs to be ruled out. Aneurysms and other vascular malformations can often be identified by CT scan or by MRI, but cerebral angiogram (conventional or CT angiogram) is the preferred method, particularly for identification of aneurysms. MRI (diffusion- and perfusion-weighted images) is best for detecting ischemic strokes and can show damaged areas that are at risk even at the earliest stages of stroke.
Carotid duplex ultrasonography, arteriography, or magnetic resonance angiography (MRA) of the carotid system may determine if stroke has occurred as a result of carotid occlusion. MRA is generally more accurate than carotid duplex studies.
The most recent U.S. Preventive Services Task Force guidelines no longer recommend routine aspirin prophylaxis for everyone. This change in recommendations comes in light of evidence that the benefits of aspirin for primary prevention of cardiovascular disease may not outweigh the risks. Aspirin is typically recommended after a cardiovascular or cerebrovascular event (such as a stroke). Individual recommendations and decisions regarding aspirin use should be made between the patient and their physician.,
If the stroke appears to be embolic in nature, a thorough search for a possible embolic source may be necessary. This search may entail a transesophageal echocardiogram (TEE)—an echocardiogram performed by placing the probe in the patient’s esophagus and stomach—to search for cardiac thrombus or interatrial shunting.
In patients with cryptogenic stroke, in addition to TEE, event monitoring or loop recording (via a small implanted cardiac monitor) may also be necessary to evaluate for cardiac arrhythmias, particularly atrial fibrillation, which is often an occult cause of stroke. If atrial fibrillation or atrial flutter is detected in patients with prior stroke, anticoagulation with warfarin or direct oral anticoagulants (DOAC) such as apixaban or rivaroxaban, among others, may be required to prevent future risk of stroke.
Basic life supportive stabilization and treatment are important in suspected stroke. Fever could be an indication of infection and should be investigated. Blood sugar should be regulated. Permissive hypertension should be supported in the acute phase of the stroke to maintain cerebral perfusion. Airway maintenance is vital, and intubation is sometimes necessary. Patients should not be allowed to consume food until their swallowing ability can be validated.
Because the intensity of stroke rehabilitation efforts is associated with the degree of recovery, many hospitals have specialized stroke-recovery units. Speech therapy, physical therapy, and occupational therapy are important treatments during rehabilitation, and should be instituted as early as possible. Regular monitoring and assessment are important to track progress and identify skill sets that may require additional rehabilitation resources.
Transient Ischemic Attack
Because the risk of recurrent strokes is high in patients who have suffered a TIA or stroke, it is essential to identify the cause and implement therapy to reduce risk.
- Antiplatelet therapy with aspirin or its alternatives (e.g., clopidogrel or aspirin plus dipyridamole) can reduce stroke risk.
- Anticoagulation is indicated if cardiac thrombi or atrial fibrillation is identified. Unless contraindicated, DOACs are preferred over warfarin due to decreased risk of major bleeding and ease of use. Investigation for cardiac abnormalities (including right to left shunts) should be considered, particularly in young patients with stroke or TIA, or if there is a high index of suspicion for embolus.
- Patients at high risk for stroke may require carotid endarterectomy within 2 weeks of the TIA if stenosis is > 70% (and sometimes > 50%) on the symptomatic side. Treatment of stenosis in asymptomatic patients remains controversial; very high-grade stenoses may warrant intervention if surgical risks are low.
- If hypercoagulability is suspected, particularly in young individuals with few stroke risk factors, screening for hypercoagulability is appropriate.
Ischemic stroke may lead to rapid secondary (2-5 days) neurologic deterioration resulting from cerebral edema or hemorrhagic conversion of infarct, and patients may be at risk for brain herniation if the infarct is large enough. Close monitoring should occur in the intensive care unit using the Glasgow Coma Scale, regular CT imaging, and possibly intracranial pressure monitoring.
Thrombolytic agents (alteplase) dissolve artery-blocking clots in the brain during the critical early stages of stroke. They are of proven benefit only when administered intravenously within 3 to 4.5 hours of stroke onset. After this time, the risk of intracerebral hemorrhage outweighs benefit. There are multiple inclusion and exclusion criteria for administration, and adverse effects can include potentially serious intracranial bleeding. Patients will require very close monitoring in an intensive care unit after receiving thrombolysis. Endovascular thrombectomy may also be performed at specialized stroke centers.
Antiplatelet agents (e.g., aspirin, aspirin-dipyridamole, clopidogrel) should be given after 24 hours of stroke if there is no contraindication.
Treatment with anticoagulation, such as low-molecular-weight heparin, warfarin, or DOAC, is generally reserved for strokes with ongoing thromboembolism. In addition, their use requires initial evaluation to exclude intracranial hemorrhage and baseline evaluation of the international normalized ratio, partial thromboplastin time, platelet count, and other tests to assess coagulation status, if indicated.
There is growing recognition of the value of aggressive lipid lowering for stroke prevention in at-risk patients and for the management of acute ischemic strokes. In most circumstances, patients should be considered for interventions immediately after recognition of their high-risk status. Beginning treatment very early after a cerebrovascular event leads to better outcomes.
Neuroprotective agents have failed to show benefits, thus far, in clinical trials.
Treatment of intracerebral hemorrhage depends on the extent of the hemorrhage, as well as its cause and location. Medical or surgical management may be indicated.
Subarachnoid hemorrhage due to an aneurysm or arteriovenous malformation requires urgent evaluation and may warrant surgery, depending on the patient’s age, clinical status, and risk of rebleeding.
The role of dietary factors in stroke is apparent from the disorder’s pathophysiology. Because ischemic strokes are caused by atherosclerosis, they are more common in the presence of high blood cholesterol concentrations, which, in turn, are strongly linked to dietary saturated fat and cholesterol, and a low fiber intake, among other contributors to cardiovascular risk. Similarly, hypertension contributes to both ischemic and hemorrhagic stroke, so diets that are high in saturated fat or sodium or low in potassium would tend to increase risk. A diet high in potassium, low in sodium, and rich in vegetables, fruits, cereal fiber, and whole grains may reduce stroke risk.
In epidemiologic studies, the following factors are associated with reduced stroke risk:
A healthy dietary pattern. Healthy dietary patterns are defined by the relative absence of foods that are energy-dense, high in saturated fats (e.g., meat and full-fat dairy products), fried, processed, or high in glycemic load. This should be accompanied by the presence of higher amounts of fruits, vegetables, soy foods and other legumes, nuts, unsaturated fats, and foods that are low in energy density and high in fiber, among other characteristics. Several systematic reviews and meta-analyses have examined the relationship between Western diets, healthy/prudent diets, Mediterranean diets, and stroke incidence. Historically, high, compared with low, adherence to either a Mediterranean pattern, or a healthy/prudent pattern, was associated with a 32% lower and 23% lower stroke risk, respectively., The Dietary Approaches to Stop Hypertension (DASH) diet has been popularly associated with reduced risk of stroke.
A publication from Harvard’s Nurses’ Health and Health Professionals cohorts with over 210,000 subjects assessed the role a plant-based diet had on stroke risk. The study included nearly 120,000 participants and concluded those who adhered to the healthiest plant-based dietary profile could expect a lower risk of total stroke.
Plant-based eating patterns may reduce the risk of stroke by reducing the risk of hypertension, the prevalence of atrial fibrillation, and the risk of obesity, obstructive sleep apnea, diabetes, atherosclerosis, and systemic inflammation. Further, plant-based eating may reduce trimethylamine-N-oxide, improve endothelial function, and increase endothelial progenitor cells. Consuming unrefined plant-based foods and limiting processed food and red and processed meat should be indicated for primary and secondary prevention of stroke. When following a vegan diet, a vitamin B12 supplement is essential.
The evidence for a vegetarian dietary pattern is promising for prevention and management of cardiovascular diseases. Not all cardiovascular disease guidelines, however, recommend following a vegetarian and/or vegan diet, or the guidelines grade the evidence as low quality. As dietary guidelines and public health policy have shifted toward food and dietary pattern-based recommendations, there is a need for systematic reviews and meta-analyses comparing the role of vegetarian/vegan diets in the prevention and management of cardiovascular diseases.
A review of 4 studies, for example, found that strong evidence supporting the efficacy of a plant-based diet in reducing atherogenic lipids, and subsequent cardiovascular events, is lacking. This is primarily because many existing studies have not followed precise methods, an inherent limitation when evaluating such a nuanced research subject as diet in the context of lifestyle. It has therefore been suggested that future studies need precision in study length, type of diet, and length of intake period. They should further control for variables such as physical activity and lipid-lowering drugs that impact lipid outcomes.
One of the most compelling examples of such a study already in existence is the Adventist Health Study-2 (AHS-2), which accomplishes its precision by specifically looking at protein intake. A total of 81,337 Seventh-day Adventist men and women were retained from recruitment between 2002 and 2007. Diet was assessed at baseline by a quantitative food frequency questionnaire and categorized into 5 dietary patterns: nonvegetarian, semi-vegetarian, pesco-vegetarian, lacto-ovo–vegetarian, and vegan.
Strong associations were found between cardiovascular disease outcomes and the animal protein factor that weighted heavily on meat products, whereas a specific plant protein factor weighted on nuts and seeds was associated with a lower risk of cardiovascular disease mortality. These relationships were mostly apparent before old age, thus impacting premature cardiovascular disease death. This strengthens the idea that protein sources may be key components of diet quality, possibly largely independent of other confounders, including vegetarian diet categories. Associations of these dietary protein factors with cardiovascular disease death cannot be easily ascribed to their correlations with other nutrients considered important for cardiovascular health. Healthy diets can therefore be advocated based on protein sources, preferring low contributions of protein from meat and higher intakes of plant protein from nuts and seeds.
Finally, a recent review by Dr. T. Colin Campbell and his group suggests a plant-based diet with adequate B12 is an effective way to reduce stroke.
Replacement of saturated fat and cholesterol with monounsaturated fat from olive oil. Individuals with higher blood cholesterol concentrations (who consume meat and other foods high in saturated fat and cholesterol) tend to have higher stroke risk., Accordingly, consuming roughly 3.5 ounces per day of red meat is associated with an 11% greater risk for stroke, while eating half that much unprocessed red meat is associated with a 13% greater risk, compared with the lowest levels of intake. In women with diabetes sampled from the Nurses’ Health Study, higher intakes of saturated fat and cholesterol—which raise blood cholesterol concentrations—were related to an increased risk for cardiovascular disease, including stroke. It is currently unknown if lowering LDL cholesterol is effective for the prevention of stroke, but unsaturated fats have modest hypocholesterolemic effects. Reviews that have compared high with low intakes of olive oil for the impact on stroke have concluded that the risk was reduced by between 17% and 26%.,
It should be noted, however, that all fats and oils are energy dense (9 calories per gram) and can interfere with weight loss efforts, and that oil-rich omnivorous diets (such as “Mediterranean diets,” are less effective for lipid-lowering than diets that omit animal products.
Fish intake. Reviews have concluded that fish consumption and the intake of long-chain omega-3 fatty acids is inversely associated with cerebrovascular disease risk, and that higher compared with lower intakes significantly reduce the risk for ischemic stroke in both men and women, and total stroke risk in women., Fish products are not free of saturated fat and cholesterol, however, and the health risks of fish contamination with pollutants such as PCBs, mercury, and dioxins should be borne in mind. For those who choose to use supplements, algae supplements which contain the DHA and EPA omega-3 fatty acids are considered a safer alternative.
Diets rich in fruits, vegetables, and dietary fiber and low in refined carbohydrates. Higher intakes of fruits and vegetables are inversely associated with the risk for stroke. A dose-response relationship exists between these, so that for every 200 g daily increment in fruit or vegetable consumption, the risk for stroke decreases by 32% and 11%, respectively. Although this meta-analysis attributed a great part of stroke protection to citrus fruits, apples/pears, and leafy vegetables, another review found that higher compared with lower dietary intakes or blood levels of lycopene (a carotenoid found almost exclusively in tomato products) were associated with an almost 20% lower stroke risk., In addition to carotenoids such as lycopene, these foods provide dietary fiber, vitamin C, vitamin E, folate, and flavonoids, all of which have been associated with reduced stroke risk in epidemiologic studies.,,,,,
Dietary fiber intake is inversely associated with stroke risk, although this effect is not attributable to the intake of whole grains.,,
Consuming less sodium and more potassium. Higher (compared with lower) sodium intake is associated with an almost 25% greater risk for stroke. Conversely, potassium intake is inversely associated with the risk for stroke.
Maintenance of healthy body weight. The risk for stroke increases with the degree of overweight, and a meta-analysis of studies including over 2 million individuals concluded that risk for stroke is 64% greater in obese individuals and 22% higher in overweight persons, compared with those who are at normal weight., Evidence supports the ability of losing excess weight to reduce future stroke risk.
Limiting alcohol consumption. Alcohol consumption may be more associated with ischemic than hemorrhagic stroke. Compared with no alcohol consumption, having 1-2 drinks per day was associated with a roughly 10% lower risk for ischemic stroke. Conversely, consumption of both 2-4 drinks per day and > 4 drinks per day was associated with an 8% and 14% greater risk, respectively. Having > 4 drinks/day was associated with a 67% and 82% greater risk for intracerebral hemorrhage and subarachnoid hemorrhage.
Adequate vitamin D status. Compared with individuals with the highest blood level of vitamin D, those with the lowest level have a 64% greater risk for stroke.
Tea and coffee. Compared with the lowest category of tea intake, consumption of 3 cups of tea each day was associated with an almost 20% lower stroke risk. When compared with those who do not drink coffee, individuals consuming 2 or more cups of coffee per day have a 13% lower risk for stroke, an association that changes little with the additional consumption of up to another 4 cups (total 6 cups/day). Beyond this level of intake, the relationship becomes nonsignificant.
Caution with vitamin E and calcium supplements. Vitamin E supplements appear to reduce the risk for ischemic stroke by 10%; however, they appear to increase the risk for hemorrhagic stroke by 22%. Calcium supplements (typically 500 - 1,000 mg daily) appear to increase stroke risk by between 12% and 20%, an effect that is not reduced by coadministration with vitamin D.
After stroke occurs, adequate nutrition is an essential part of clinical care. Malnutrition is frequently observed after a stroke has occurred, and while roughly 20% of patients with acute stroke have been found malnourished on admission, other studies have shown that between 56% and 61% develop malnutrition at some point during hospital stays of > 3 weeks. In the FOOD Trial Collaboration, poor nutritional status was associated with worse outcomes at 6 months poststroke.
Patients who have had a stroke should have an assessment by a speech therapist of their swallowing ability before resuming eating or drinking. One study found that between 42% and 67% of stroke patients have dysphagia. If they cannot take food and fluids orally, they should receive enteral feedings using a nasogastric, nasoduodenal, or percutaneous endoscopic gastrostomy tube to maintain hydration and nutrition while undergoing efforts to restore swallowing. Typically, adequate swallowing mechanics return within the first 2 weeks poststroke. Nutritional supplements do not appear to be necessary or beneficial in these patients, unless required for an indication other than stroke. In undernourished stroke patients, however, protein-calorie-micronutrient supplement combinations significantly improved motor function, allowing a significantly higher proportion of patients to return home when compared with those not given supplements.
Apart from dysphagia, reduced level of consciousness, poor oral hygiene, depression, reduced mobility, arm or facial weakness, and poststroke depression can all influence food intake and nutritional status. The measurement of serum proteins, however, (e.g., albumin) is not a reliable indicator of nutritional status because it is unclear whether these decrease due to malnutrition or inflammation.
Although (as noted above) obesity is a risk factor for stroke, paradoxically, being overweight or obese is associated with significantly lower mortality 5 to 10 years after stroke than being either normal weight or overweight. This does not imply a health benefit of obesity so much as a higher morbidity that comes from the negative long-term effects of a stroke and their impact on appetite and food intake.
See Basic Diet Orders chapter.
Sodium intake less than 2 g daily.
Physical/occupational therapy consultation for home safety evaluation.
Stroke rehabilitation, as well as speech and swallowing therapy, as appropriate.
What to Tell the Family
Stroke occurs more frequently among those of advanced age and those who have blood vessel disease, family or previous history of stroke, and poor blood pressure control. Persons who eat diets rich in fruits, vegetables, and fiber and low in saturated fat, cholesterol, and sodium decrease their risk for stroke, as do those who quit smoking, drink alcohol minimally, and engage in regular physical activity. It is important for the patient and family to follow a similar healthful diet in order to decrease the risk of future stroke. Timing of care is critical to treatment success. Family members should be aware of the warning signs of stroke and immediately seek emergency care if these signs occur.
- Centers for Disease Control and Prevention. Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/hus/hus15.pdf. Accessed December 15, 2020.
- Writing Group Members, Mozaffarian D, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133(4):e38-360. [PMID:26673558]
- Lioutas VA, Ivan CS, Himali JJ, et al. Incidence of Transient Ischemic Attack and Association With Long-term Risk of Stroke. JAMA. 2021;325(4):373-381. [PMID:33496774]
- Centers for Disease Control and Prevention (CDC). Prevalence of stroke--United States, 2005. MMWR Morb Mortal Wkly Rep. 2007;56(19):469-74. [PMID:17510610]
- Brown RD, Whisnant JP, Sicks JD, et al. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke. 1996;27(3):373-80. [PMID:8610298]
- Whisnant JP. Modeling of risk factors for ischemic stroke. The Willis Lecture. Stroke. 1997;28(9):1840-4. [PMID:9303034]
- Kleindorfer DO, Khoury J, Moomaw CJ, et al. Stroke incidence is decreasing in whites but not in blacks: a population-based estimate of temporal trends in stroke incidence from the Greater Cincinnati/Northern Kentucky Stroke Study. Stroke. 2010;41(7):1326-31. [PMID:20489177]
- Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects), Lu Y, Hajifathalian K, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet. 2014;383(9921):970-83. [PMID:24269108]
- Chen R, Ovbiagele B, Feng W. Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes. Am J Med Sci. 2016;351(4):380-6. [PMID:27079344]
- Wendel-Vos GC, Schuit AJ, Feskens EJ, et al. Physical activity and stroke. A meta-analysis of observational data. Int J Epidemiol. 2004;33(4):787-98. [PMID:15166195]
- Wessel TR, Arant CB, Olson MB, et al. Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA. 2004;292(10):1179-87. [PMID:15353530]
- Barnett HJ, Gunton RW, Eliasziw M, et al. Causes and severity of ischemic stroke in patients with internal carotid artery stenosis. JAMA. 2000;283(11):1429-36. [PMID:10732932]
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983-8. [PMID:1866765]
- Stang PE, Carson AP, Rose KM, et al. Headache, cerebrovascular symptoms, and stroke: the Atherosclerosis Risk in Communities Study. Neurology. 2005;64(9):1573-7. [PMID:15883318]
- Roach RE, Helmerhorst FM, Lijfering WM, et al. Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke. Cochrane Database Syst Rev. 2015;8:CD011054. [PMID:26310586]
- US Preventive Services Task Force, Davidson KW, Barry MJ, et al. Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement. JAMA. 2022;327(16):1577-1584. [PMID:35471505]
- Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. [PMID:30879355]
- Kwakkel G, Wagenaar RC, Koelman TW, et al. Effects of intensity of rehabilitation after stroke. A research synthesis. Stroke. 1997;28(8):1550-6. [PMID:9259747]
- Paciaroni M, Hennerici M, Agnelli G, et al. Statins and stroke prevention. Cerebrovasc Dis. 2007;24(2-3):170-82. [PMID:17596685]
- Ding EL, Mozaffarian D. Optimal dietary habits for the prevention of stroke. Semin Neurol. 2006;26(1):11-23. [PMID:16479440]
- Kontogianni MD, Panagiotakos DB. Dietary patterns and stroke: a systematic review and re-meta-analysis. Maturitas. 2014;79(1):41-7. [PMID:25042875]
- Zhang X, Shu L, Si C, et al. Dietary Patterns and Risk of Stroke in Adults: A Systematic Review and Meta-analysis of Prospective Cohort Studies. J Stroke Cerebrovasc Dis. 2015;24(10):2173-82. [PMID:26232888]
- Dearborn JL, Urrutia VC, Kernan WN. The case for diet: a safe and efficacious strategy for secondary stroke prevention. Front Neurol. 2015;6:1. [PMID:25699006]
- Baden MY, Shan Z, Wang F, et al. Quality of Plant-Based Diet and Risk of Total, Ischemic, and Hemorrhagic Stroke. Neurology. 2021;96(15):e1940-e1953. [PMID:33692165]
- Campbell T. A plant-based diet and stroke. J Geriatr Cardiol. 2017;14(5):321-326. [PMID:28630610]
- ClinicalKey for Nursing. Relation of vegetarian diets with incident cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies. First received on July 16, 2018. Last updated on July 25, 2018. Accessed June 23, 2022. https://www.clinicalkey.com/nursing/#!/content/clinical_trial/24-s2.0-NCT03610828...
- Ware KM. Are plant-based diets efficacious in lowering total serum cholesterol and low-density lipoprotein levels? J Vasc Nurs. 2014;32(2):46-50. [PMID:24944170]
- Tharrey M, Mariotti F, Mashchak A, et al. Patterns of plant and animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort. Int J Epidemiol. 2018;47(5):1603-1612. [PMID:29618018]
- Koren-Morag N, Tanne D, Graff E, et al. Low- and high-density lipoprotein cholesterol and ischemic cerebrovascular disease: the bezafibrate infarction prevention registry. Arch Intern Med. 2002;162(9):993-9. [PMID:11996608]
- Leppälä JM, Virtamo J, Fogelholm R, et al. Different risk factors for different stroke subtypes: association of blood pressure, cholesterol, and antioxidants. Stroke. 1999;30(12):2535-40. [PMID:10582974]
- Wolk A. Potential health hazards of eating red meat. J Intern Med. 2017;281(2):106-122. [PMID:27597529]
- Tanasescu M, Cho E, Manson JE, et al. Dietary fat and cholesterol and the risk of cardiovascular disease among women with type 2 diabetes. Am J Clin Nutr. 2004;79(6):999-1005. [PMID:15159229]
- Zanchetti A, Liu L, Mancia G, et al. Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence. J Hypertens. 2014;32(9):1741-50. [PMID:24979302]
- Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review and meta-analysis of cohort studies. Lipids Health Dis. 2014;13:154. [PMID:25274026]
- Martínez-González MA, Dominguez LJ, Delgado-Rodríguez M. Olive oil consumption and risk of CHD and/or stroke: a meta-analysis of case-control, cohort and intervention studies. Br J Nutr. 2014;112(2):248-59. [PMID:24775425]
- Chowdhury R, Stevens S, Gorman D, et al. Association between fish consumption, long chain omega 3 fatty acids, and risk of cerebrovascular disease: systematic review and meta-analysis. BMJ. 2012;345:e6698. [PMID:23112118]
- Li D. Omega-3 polyunsaturated fatty acids and non-communicable diseases: meta-analysis based systematic review. Asia Pac J Clin Nutr. 2015;24(1):10-5. [PMID:25740737]
- Peltomaa E, Johnson MD, Taipale SJ. Marine Cryptophytes Are Great Sources of EPA and DHA. Mar Drugs. 2017;16(1). [PMID:29278384]
- Hu D, Huang J, Wang Y, et al. Fruits and vegetables consumption and risk of stroke: a meta-analysis of prospective cohort studies. Stroke. 2014;45(6):1613-9. [PMID:24811336]
- Li X, Xu J. Dietary and circulating lycopene and stroke risk: a meta-analysis of prospective studies. Sci Rep. 2014;4:5031. [PMID:24848940]
- Hak AE, Ma J, Powell CB, et al. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke. 2004;35(7):1584-8. [PMID:15178820]
- Hirvonen T, Virtamo J, Korhonen P, et al. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke. 2000;31(10):2301-6. [PMID:11022054]
- Vokó Z, Hollander M, Hofman A, et al. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology. 2003;61(9):1273-5. [PMID:14610137]
- Threapleton DE, Greenwood DC, Evans CE, et al. Dietary fiber intake and risk of first stroke: a systematic review and meta-analysis. Stroke. 2013;44(5):1360-8. [PMID:23539529]
- Chen GC, Lu DB, Pang Z, et al. Vitamin C intake, circulating vitamin C and risk of stroke: a meta-analysis of prospective studies. J Am Heart Assoc. 2013;2(6):e000329. [PMID:24284213]
- Bazzano LA, He J, Ogden LG, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. National Health and Nutrition Examination Survey. Stroke. 2002;33(5):1183-8. [PMID:11988588]
- Li B, Zhang G, Tan M, et al. Consumption of whole grains in relation to mortality from all causes, cardiovascular disease, and diabetes: Dose-response meta-analysis of prospective cohort studies. Medicine (Baltimore). 2016;95(33):e4229. [PMID:27537552]
- Aune D, Keum N, Giovannucci E, et al. Whole grain consumption and risk of cardiovascular disease, cancer, and all cause and cause specific mortality: systematic review and dose-response meta-analysis of prospective studies. BMJ. 2016;353:i2716. [PMID:27301975]
- Aburto NJ, Ziolkovska A, Hooper L, et al. Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ. 2013;346:f1326. [PMID:23558163]
- Aburto NJ, Hanson S, Gutierrez H, et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013;346:f1378. [PMID:23558164]
- Suk SH, Sacco RL, Boden-Albala B, et al. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2003;34(7):1586-92. [PMID:12775882]
- Strazzullo P, D'Elia L, Cairella G, et al. Excess body weight and incidence of stroke: meta-analysis of prospective studies with 2 million participants. Stroke. 2010;41(5):e418-26. [PMID:20299666]
- Look AHEAD Research Group, Gregg EW, Jakicic JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol. 2016;4(11):913-921. [PMID:27595918]
- Larsson SC, Wallin A, Wolk A, et al. Differing association of alcohol consumption with different stroke types: a systematic review and meta-analysis. BMC Med. 2016;14(1):178. [PMID:27881167]
- Wang L, Song Y, Manson JE, et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes. 2012;5(6):819-29. [PMID:23149428]
- Zhang C, Qin YY, Wei X, et al. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30(2):103-13. [PMID:25354990]
- Larsson SC. Coffee, tea, and cocoa and risk of stroke. Stroke. 2014;45(1):309-14. [PMID:24326448]
- Schürks M, Glynn RJ, Rist PM, et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ. 2010;341:c5702. [PMID:21051774]
- Reid IR. Cardiovascular effects of calcium supplements. Nutrients. 2013;5(7):2522-9. [PMID:23857224]
- Bouziana SD, Tziomalos K. Malnutrition in patients with acute stroke. J Nutr Metab. 2011;2011:167898. [PMID:22254136]
- FOOD Trial Collaboration. Poor nutritional status on admission predicts poor outcomes after stroke: observational data from the FOOD trial. Stroke. 2003;34(6):1450-6. [PMID:12750536]
- Drozdz D, Mancopes R, Silva AM, et al. Analysis of the level of Dysphagia, anxiety, and nutritional status before and after speech therapy in patients with stroke. Int Arch Otorhinolaryngol. 2014;18(2):172-7. [PMID:25992086]
- Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(5):1655-711. [PMID:17431204]
- Rabadi MH, Coar PL, Lukin M, et al. Intensive nutritional supplements can improve outcomes in stroke rehabilitation. Neurology. 2008;71(23):1856-61. [PMID:18946003]
- Scherbakov N, Dirnagl U, Doehner W. Body weight after stroke: lessons from the obesity paradox. Stroke. 2011;42(12):3646-50. [PMID:21960580]